Standout Papers

Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders 2005 2026 2012 2019 2.5k
  1. Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders (2005)
    E. Joanna Baxter, Linda M. Scott et al. The Lancet
  2. Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders (2005)
    E. Joanna Baxter, Linda M. Scott et al. The Lancet
  3. Hydroxyurea Compared with Anagrelide in High-Risk Essential Thrombocythemia (2005)
    Claire Harrison, Peter J. Campbell et al. New England Journal of Medicine

Immediate Impact

3 by Nobel laureates 29 from Science/Nature 90 standout
Sub-graph 1 of 19

Citing Papers

JAK inhibition enhances checkpoint blockade immunotherapy in patients with Hodgkin lymphoma
2024 StandoutScience
Depleting myeloid-biased haematopoietic stem cells rejuvenates aged immunity
2024 StandoutNature
4 intermediate papers

Works of Clare East being referenced

Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders
2005 Standout
Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders
2005 Standout

Author Peers

Author Last Decade Papers Cites
Clare East 4114 2676 2530 12 4.6k
Elaine Boyd 3611 2336 2204 9 4.1k
S Swanton 3047 2194 1841 11 3.6k
Nasios Fourouclas 3023 2048 1833 8 3.5k
Natasha Joan Curtin 2969 1987 1752 6 3.4k
Jean‐Pierre Le Couedic 2373 2107 1609 18 3.6k
Ralph Tiedt 2795 2336 2261 33 4.4k
Catherine Lacout 3221 2545 2129 47 4.2k
Judith Staerk 2846 1967 3062 34 4.9k
Anthony J. Bench 4800 3502 3197 47 6.0k
Mike Scott 4254 2994 3003 46 5.8k

All Works

Loading papers...

Rankless by CCL
2026